This is a table of type trigram and their frequencies. Use it to search & browse the list to learn more about your study carrel.
trigram | frequency |
---|---|
j am acad | 32 |
acad dermatol doi | 32 |
am acad dermatol | 32 |
in patients with | 27 |
the risk of | 21 |
efficacy and safety | 20 |
and safety of | 18 |
during the covid | 15 |
risk of rtis | 14 |
patients with moderate | 12 |
the treatment of | 12 |
moderate to severe | 11 |
in the era | 10 |
the era of | 10 |
safety of ustekinumab | 10 |
for the treatment | 9 |
in the treatment | 9 |
in order to | 8 |
of the covid | 8 |
in clinical trials | 8 |
consultant and or | 8 |
series of patients | 7 |
case series of | 7 |
as a consultant | 7 |
the use of | 7 |
tumor necrosis factor | 7 |
respiratory syndrome coronavirus | 7 |
biologics for psoriasis | 7 |
a consultant and | 7 |
during the pandemic | 7 |
with moderate to | 6 |
the treatment group | 6 |
acute respiratory syndrome | 6 |
due to the | 6 |
positive predictive value | 6 |
and or speaker | 6 |
results of a | 6 |
interrupted in the | 6 |
participated in clinical | 6 |
be interrupted in | 6 |
psoriasis be interrupted | 6 |
for psoriasis be | 6 |
results from a | 6 |
should biologics for | 6 |
severe acute respiratory | 6 |
chronic plaque psoriasis | 6 |
era of covid | 6 |
of the study | 5 |
of the disease | 5 |
r o o | 5 |
n a l | 5 |
p r e | 5 |
to the editor | 5 |
p r o | 5 |
we read with | 5 |
patients treated with | 5 |
o o f | 5 |
o u r | 5 |
the development of | 5 |
r n a | 5 |
age and sex | 5 |
of this study | 5 |
or speaker for | 5 |
patients during the | 5 |
allergic contact dermatitis | 5 |
personal protective equipment | 5 |
treatment of psoriasis | 5 |
or participated in | 5 |
used in the | 5 |
psoriasis efficacy and | 5 |
for and or | 5 |
u r n | 5 |
l p r | 5 |
a systematic review | 5 |
and or participated | 5 |
a l p | 5 |
of the manuscript | 5 |
type i ifn | 5 |
patients with covid | 5 |
j o u | 5 |
increased risk of | 5 |
speaker for and | 5 |
systematic review and | 5 |
do not have | 4 |
patients with active | 4 |
manufacture drugs used | 4 |
base population and | 4 |
american academy of | 4 |
acted as a | 4 |
used for the | 4 |
of hospitalized covid | 4 |
skin is a | 4 |
host of sars | 4 |
companies that manufacture | 4 |
safety and efficacy | 4 |
a case series | 4 |
is a potential | 4 |
academy of dermatology | 4 |
by companies that | 4 |
overall risk of | 4 |
skin ace expression | 4 |
interstitial lung disease | 4 |
to severe psoriasis | 4 |
of infectious pneumonia | 4 |
compared to placebo | 4 |
has served as | 4 |
the positive predictive | 4 |
trial efficacy and | 4 |
safety of guselkumab | 4 |
in japanese patients | 4 |
review and meta | 4 |
the care of | 4 |
potential host of | 4 |
sponsored by companies | 4 |
a human interleukin | 4 |
the overall risk | 4 |
residents and the | 4 |
risk of covid | 4 |
the potential for | 4 |
been reported in | 4 |
infectious pneumonia and | 4 |
jak inhibitors in | 4 |
and efficacy of | 4 |
of patients with | 4 |
very severe baldness | 4 |
of ustekinumab in | 4 |
treatment of moderate | 4 |
the production of | 4 |
care of covid | 4 |
heterogeneity was absent | 4 |
in the skin | 4 |
a potential host | 4 |
residency application process | 4 |
from a phase | 4 |
and the care | 4 |
drugs used for | 4 |
the gabrin sign | 4 |
in autoimmune diseases | 4 |
of rtis and | 4 |
that manufacture drugs | 4 |
viral immune response | 4 |
the current covid | 3 |
study suggests that | 3 |
cutaneous manifestations of | 3 |
medical face masks | 3 |
cytokines and antibodies | 3 |
in psoriatic patients | 3 |
the safety of | 3 |
limitations of this | 3 |
surgical procedure masks | 3 |
the incidence of | 3 |
and biologic therapies | 3 |
randomized clinical trial | 3 |
associated skin manifestation | 3 |
treated with biological | 3 |
is a preservative | 3 |
type i interferon | 3 |
patients with psoriasis | 3 |
the skin ace | 3 |
respiratory tract infections | 3 |
read with great | 3 |
that did not | 3 |
patients with chronic | 3 |
severe plaque psoriasis | 3 |
the diagnosis of | 3 |
for severe covid | 3 |
results from the | 3 |
that it is | 3 |
in response to | 3 |
in the dermatology | 3 |
but not viral | 3 |
facial protective equipment | 3 |
the majority of | 3 |
the lack of | 3 |
increased the risk | 3 |
response to the | 3 |
pneumonia and ild | 3 |
program director panelists | 3 |
the time of | 3 |
with systemic therapies | 3 |
to severe chronic | 3 |
to understand the | 3 |
rtis and non | 3 |
the impact of | 3 |
the united states | 3 |
in our study | 3 |
not have a | 3 |
era of the | 3 |
biologic therapies for | 3 |
involved in the | 3 |
of a randomized | 3 |
has been demonstrated | 3 |
served as a | 3 |
the spread of | 3 |
that out of | 3 |
the coronavirus disease | 3 |
a total of | 3 |
incidence of covid | 3 |
clinical trials sponsored | 3 |
was associated with | 3 |
of biologic agents | 3 |
those that did | 3 |
is associated with | 3 |
treated with systemic | 3 |
with great interest | 3 |
i ifn response | 3 |
support from the | 3 |
psoriatic patients treated | 3 |
we performed a | 3 |
nan to the | 3 |
not viral urtis | 3 |
a phase iii | 3 |
from the phase | 3 |
of patients seen | 3 |
have been reported | 3 |
there was no | 3 |
diagnosis of covid | 3 |
this study include | 3 |
a specific covid | 3 |
seen in teledermatology | 3 |
results of the | 3 |
associated with worse | 3 |
has not been | 3 |
like exanthem as | 3 |
we found that | 3 |
herpes simplex zoster | 3 |
androgenetic alopecia in | 3 |
a case report | 3 |
is used in | 3 |
in the united | 3 |
the viral immune | 3 |
japanese patients with | 3 |
for psoriasis and | 3 |
as a specific | 3 |
participated as ab | 3 |
for systematic reviews | 3 |
msd and pfizer | 3 |
dermatology residents and | 3 |
in addition to | 3 |
expression of ace | 3 |
infected with sars | 3 |
of patients receiving | 3 |
severe chronic plaque | 3 |
trials sponsored by | 3 |
the role of | 3 |
present in the | 3 |
cutaneous manifestations in | 3 |
of the pandemic | 3 |
randomized controlled trials | 3 |
exanthem as a | 3 |
a randomized trial | 3 |
we randomly selected | 3 |
the quality of | 3 |
patients seen in | 3 |
a word of | 3 |
in light of | 3 |
multicenter case series | 3 |
majority of hospitalized | 3 |
speaker for janssen | 3 |
patients in the | 3 |
head and neck | 3 |
therapies for psoriasis | 3 |
infections in moderate | 2 |
and is used | 2 |
it to the | 2 |
the presence of | 2 |
and histological study | 2 |
due to severe | 2 |
the pandemic has | 2 |
yiv rp y | 2 |
reviewed all biobadaderm | 2 |
defined as the | 2 |
no previous co | 2 |
a vocation is | 2 |
and conduct of | 2 |
the need for | 2 |
ionic surfactants and | 2 |
between the spanish | 2 |
with worse outcomes | 2 |
in age and | 2 |
are derived from | 2 |
all active patients | 2 |
derivatives contact allergenic | 2 |
we reviewed all | 2 |
plot was not | 2 |
summarized in table | 2 |
not done during | 2 |
in patients receiving | 2 |
on patients with | 2 |
that of the | 2 |
we divided rtis | 2 |
polyethylene glycol derivatives | 2 |
in the time | 2 |
latest data updated | 2 |
is promoted by | 2 |
placebo for weeks | 2 |
n respirator identified | 2 |
cohort study suggests | 2 |
clinical trials to | 2 |
detection of sars | 2 |
meet inclusion criteria | 2 |
diagnosis and treatment | 2 |
prior to the | 2 |
the ratio of | 2 |
often not done | 2 |
that we know | 2 |
during the trials | 2 |
but with higher | 2 |
a control group | 2 |
needs of patients | 2 |
current active patients | 2 |
access to care | 2 |
to the pandemic | 2 |
within the cohort | 2 |
biological drugs compared | 2 |
alopecia in covid | 2 |
following companies have | 2 |
icu and death | 2 |
what it is | 2 |
peak of the | 2 |
related to outcomes | 2 |
polymerase chain reaction | 2 |
testing was often | 2 |
therapies and to | 2 |
infection control in | 2 |
compared to the | 2 |
with hidradenitis suppurativa | 2 |
before and after | 2 |
data suggest that | 2 |
formaldehyde is a | 2 |
occupational dermatitis to | 2 |
a byproduct of | 2 |
have also been | 2 |
detailed in table | 2 |
piel sana academia | 2 |
systematic reviews and | 2 |
strengthen their applications | 2 |
confirmed cases published | 2 |
i did not | 2 |
likely suffer from | 2 |
cases of mild | 2 |
widely used in | 2 |
through virtual visits | 2 |
novartis and pfizer | 2 |
to confirm them | 2 |
based on the | 2 |
other viral infections | 2 |
cases was similar | 2 |
or diabetes mellitus | 2 |
may prove useful | 2 |
clinical trials for | 2 |
immunomodulators immunosuppressants during | 2 |
be an important | 2 |
figures and biobadaderm | 2 |
with interest the | 2 |
psoriatic patients during | 2 |
the limitations of | 2 |
with chronic plaque | 2 |
contact dermatitis was | 2 |
frequencies for covid | 2 |
innovative ways to | 2 |
were calculated for | 2 |
ventilator for days | 2 |
submit the manuscript | 2 |
patients receiving adalimumab | 2 |
degradation during production | 2 |
seems to be | 2 |
classic systemic drugs | 2 |
a prospective cohort | 2 |
plaque psoriasis efficacy | 2 |
and interstitial lung | 2 |
in place for | 2 |
that suggests that | 2 |
specific study within | 2 |
hydroxychloroquine use for | 2 |
for herpesvirus and | 2 |
of these events | 2 |
compared to pcr | 2 |
j b p | 2 |
risk in patients | 2 |
been shown to | 2 |
patients included in | 2 |
receiving biologic treatments | 2 |
as an allergen | 2 |
objective was to | 2 |
best suited for | 2 |
quality of evidence | 2 |
the period of | 2 |
of polypropylene degradation | 2 |
patients with relapsing | 2 |
believe there is | 2 |
when compared to | 2 |
and paper products | 2 |
resins in surgical | 2 |
evaluation of lesion | 2 |
of current active | 2 |
to compare it | 2 |
lesions have been | 2 |
be associated with | 2 |
to what it | 2 |
study therefore avoids | 2 |
could reduce the | 2 |
that classic systemic | 2 |
first data were | 2 |
prospective cohort study | 2 |
we believe there | 2 |
in spain with | 2 |
respirator identified formaldehyde | 2 |
lack of serological | 2 |
to severe plaque | 2 |
companies were not | 2 |
significantly increased risk | 2 |
a preservative and | 2 |
procedure masks and | 2 |
time of the | 2 |
of all possible | 2 |
treatment of cellulitis | 2 |
from the new | 2 |
polyethylene glycols and | 2 |
our primary objective | 2 |
manuscript for publication | 2 |
the skin of | 2 |
infection or nasopharyngitis | 2 |
biologic treatments are | 2 |
found that out | 2 |
as ab from | 2 |
described as an | 2 |
spanish ministry of | 2 |
the need to | 2 |
al sandborn et | 2 |
we can calculate | 2 |
the fatality rate | 2 |
increase neither the | 2 |
use for covid | 2 |
sir to compare | 2 |
we used the | 2 |
medicines and health | 2 |
may be a | 2 |
percentages of comorbidities | 2 |
as the authors | 2 |
conflicts of interest | 2 |
manifestations in covid | 2 |
dermatology application cycle | 2 |
patients experiencing homelessness | 2 |
and those that | 2 |
of infection was | 2 |
as compared to | 2 |
did not recur | 2 |
reassuring at the | 2 |
items for systematic | 2 |
during the period | 2 |
the analysis with | 2 |
nationwide consensus study | 2 |
patients due to | 2 |
year results of | 2 |
ratio of the | 2 |
gallego infections in | 2 |
main analysis examined | 2 |
to that of | 2 |
from selection bias | 2 |
profile of covid | 2 |
peroxides in polyethylene | 2 |
analyzed a prospective | 2 |
placebo in patients | 2 |
use of il | 2 |
is insufficient evidence | 2 |
and did not | 2 |
hospital universitario de | 2 |
of other ongoing | 2 |
in healthy subjects | 2 |
adults with moderate | 2 |
during the month | 2 |
of hydroxychloroquine use | 2 |
the spanish population | 2 |
induction and maintenance | 2 |
and psoriatic arthritis | 2 |
financial support from | 2 |
cycle in the | 2 |
and death in | 2 |
a robust anti | 2 |
a dermatologic manifestation | 2 |
a combined average | 2 |
a rapid prospective | 2 |
risk to patients | 2 |
treatment of patients | 2 |
viral type i | 2 |
number of cases | 2 |
from the spanish | 2 |
with active psoriatic | 2 |
iii clinical trials | 2 |
in the department | 2 |
primary objective was | 2 |
of janus kinase | 2 |
of the population | 2 |
in patients who | 2 |
the design and | 2 |
promoted by the | 2 |
project is promoted | 2 |
contact allergenic activity | 2 |
a randomized clinical | 2 |
approval of the | 2 |
a first perspective | 2 |
similar to that | 2 |
treatment group compared | 2 |
there has been | 2 |
also ci were | 2 |
increase the risk | 2 |
outcomes such as | 2 |
highlight the need | 2 |
had suffered from | 2 |
severe psoriasis patients | 2 |
not recur upon | 2 |
policies in place | 2 |
and of polyethylene | 2 |
ways to meet | 2 |
avoids problems of | 2 |
spanish figures and | 2 |
that a patient | 2 |
during production of | 2 |
confirm them using | 2 |
for cellulitis treatment | 2 |
byproduct of polypropylene | 2 |
of tween before | 2 |
of extensive debate | 2 |
etanercept and placebo | 2 |
associated with covid | 2 |
which do not | 2 |
and the risk | 2 |
standardized incidence ratio | 2 |
wall street journal | 2 |
the included studies | 2 |
permitted concomitant drugs | 2 |
textile resins in | 2 |
value for covid | 2 |
the latest data | 2 |
there is insufficient | 2 |
in these patients | 2 |
and nonwoven textile | 2 |
and after air | 2 |
this systematic review | 2 |
in polyethylene glycols | 2 |
nonwoven textile masks | 2 |
receives financial support | 2 |
of rcts which | 2 |
infection in patients | 2 |
drugs compared to | 2 |
a qd xdr | 2 |
patient safety and | 2 |
ncov acute respiratory | 2 |
production of resins | 2 |
one case report | 2 |
immunomodulator immunosuppressant use | 2 |
to the clinical | 2 |
the subject of | 2 |
and active comparator | 2 |
international medical students | 2 |
of healthcare workers | 2 |
serological or molecular | 2 |
insufficient evidence to | 2 |
we analyzed a | 2 |
significance between the | 2 |
information about current | 2 |
conduct of the | 2 |
the spanish ministry | 2 |
teledermatology visits for | 2 |
welldefined base population | 2 |
study efficacy and | 2 |
population and likely | 2 |
biobadaderm project is | 2 |
severe outcomes in | 2 |
preferred to hospital | 2 |
a strength of | 2 |
androgenetic alopecia present | 2 |
impact of the | 2 |
figure s b | 2 |
health products agency | 2 |
analysis and interpretation | 2 |
the virus and | 2 |
was not significantly | 2 |
response in patients | 2 |
to compare significance | 2 |
can calculate the | 2 |
contact dermatitis from | 2 |
patients with systemic | 2 |
surfactants and of | 2 |
severe atopic dermatitis | 2 |
the month of | 2 |
prospective studies of | 2 |
of rtis was | 2 |
would like to | 2 |
de la cueva | 2 |
therapies during the | 2 |
also collaborated in | 2 |
of duplicates and | 2 |
is that we | 2 |
the susceptibility nor | 2 |
with adalimumab for | 2 |
activity of tween | 2 |
the main analysis | 2 |
average of two | 2 |
we would like | 2 |
evidence to recommend | 2 |
the gastrointestinal tract | 2 |
to the spanish | 2 |
older than years | 2 |
treatments increase neither | 2 |
results from two | 2 |
for the diagnosis | 2 |
h kihj w | 2 |
interleukin monoclonal antibody | 2 |
the disease testing | 2 |
psoriasis patients treated | 2 |
was to analyze | 2 |
a cohort of | 2 |
been described as | 2 |
them using prospective | 2 |
characterization of acute | 2 |
trials as ip | 2 |
and polyethylene glycol | 2 |
tween before and | 2 |
as consultant and | 2 |
our institution in | 2 |
home care is | 2 |
of asynchronous teledermatology | 2 |
dermatology residency program | 2 |
from pharmaceutical companies | 2 |
active patients with | 2 |
a patient with | 2 |
suggests that classic | 2 |
of patients during | 2 |
institution in april | 2 |
in n respirators | 2 |
among healthcare workers | 2 |
according to the | 2 |
at the start | 2 |
cells of rectal | 2 |
been the subject | 2 |
in moderate to | 2 |
is a combined | 2 |
chemical evaluation of | 2 |
in surgical uniforms | 2 |
is widely used | 2 |
and patient safety | 2 |
paid speaker for | 2 |
disease control and | 2 |
the patients when | 2 |
and risk factors | 2 |
although the first | 2 |
use of systemic | 2 |
population and that | 2 |
molecular confirmations for | 2 |
study within the | 2 |
nieto et al | 2 |
contacted the patients | 2 |
the glandular cells | 2 |
week results from | 2 |
all possible cases | 2 |
which is the | 2 |
these data suggest | 2 |
pharmaceutical companies were | 2 |
the first data | 2 |
response to sars | 2 |
this is not | 2 |
et al sandborn | 2 |
collaborating pharmaceutical companies | 2 |
susceptibility nor the | 2 |
are not associated | 2 |
compared to classic | 2 |
ischemic lesions in | 2 |
deteriorated barrier and | 2 |
were reassuring at | 2 |
the outpatient setting | 2 |
from the biobadaderm | 2 |
from the content | 2 |
facial contact dermatitis | 2 |
ustekinumab for the | 2 |
because in cases | 2 |
study is that | 2 |
as the ratio | 2 |
glycols peroxides in | 2 |
design and conduct | 2 |
each sir to | 2 |
we conducted a | 2 |
the american academy | 2 |
of jak inhibitors | 2 |
light of the | 2 |
to analyze the | 2 |
our main analysis | 2 |
a preliminary study | 2 |
patient records and | 2 |
the onset of | 2 |
members of the | 2 |
adalimumab for the | 2 |
at the end | 2 |
the base population | 2 |
the dermatologic needs | 2 |
the severity of | 2 |
the risks of | 2 |
of the mask | 2 |
were older than | 2 |
on the use | 2 |
and contacted the | 2 |
receiving adalimumab qw | 2 |
dermatitis from formaldehyde | 2 |
treatments are not | 2 |
ustekinumab in japanese | 2 |
by marzano and | 2 |
and maintenance therapy | 2 |
of these drugs | 2 |
analyze the incidence | 2 |
from formaldehyde textile | 2 |
we hypothesize that | 2 |
outcomes in all | 2 |
in the outpatient | 2 |
some authors consider | 2 |
patients who were | 2 |
and sex standardized | 2 |
of patients experiencing | 2 |
contact dermatitis in | 2 |
to classic systemic | 2 |
or paid speaker | 2 |
the front line | 2 |
based on case | 2 |
of patients who | 2 |
for our patients | 2 |
removal of duplicates | 2 |
of the sars | 2 |
group and placebo | 2 |
in the majority | 2 |
and health products | 2 |
of polyethylene glycols | 2 |
which was supported | 2 |
allergenic activity of | 2 |
nan we read | 2 |
surgical uniforms and | 2 |
increased in the | 2 |
mild courses of | 2 |
are detailed in | 2 |
or placebo for | 2 |
visits conducted during | 2 |
compared with adalimumab | 2 |
patients of the | 2 |
collected information about | 2 |
dermatologic needs of | 2 |
fp phk p | 2 |
in pioneer and | 2 |
this type of | 2 |
this prospective cohort | 2 |
that we can | 2 |
risk of bias | 2 |
active patients of | 2 |
was supported by | 2 |
did not meet | 2 |
compare it to | 2 |
of rectal epithelia | 2 |
used the latest | 2 |
was similar to | 2 |
not associated with | 2 |
descriptive frequencies for | 2 |
a previously described | 2 |
and likely suffer | 2 |
that there is | 2 |
profiling and histological | 2 |
advances in skin | 2 |
psoriasis and psoriatic | 2 |
formaldehyde textile resins | 2 |
that covid toes | 2 |
which permitted concomitant | 2 |
msd and celgene | 2 |
from a randomised | 2 |
expected number of | 2 |
it is necessary | 2 |
or biologic treatments | 2 |
the peak of | 2 |
which receives financial | 2 |
of serological or | 2 |
to minimize the | 2 |
confirmed patients included | 2 |
study in spain | 2 |
the funnel plot | 2 |
of ustekinumab for | 2 |
if skin is | 2 |
other ongoing international | 2 |
during the current | 2 |
application cycle in | 2 |
prospective nationwide consensus | 2 |
medical advice requests | 2 |
subject of extensive | 2 |
reviews and meta | 2 |
those at the | 2 |
interested in dermatology | 2 |
suffer from selection | 2 |
suffered from covid | 2 |
the generosity of | 2 |
current comorbidities related | 2 |
adverse skin reactions | 2 |
predictive value for | 2 |
reported in the | 2 |
performed a specific | 2 |
death in pcr | 2 |
the prisma statement | 2 |
systemic therapies and | 2 |
with adequate denominators | 2 |
great interest the | 2 |
international registries based | 2 |
a lower risk | 2 |
and placebo in | 2 |
the expression of | 2 |
has been described | 2 |
that psoriatic patients | 2 |
for dermatology applicants | 2 |
start of the | 2 |
in cases of | 2 |
rapid prospective nationwide | 2 |
production of the | 2 |
of ild was | 2 |
period of the | 2 |
the manuscript for | 2 |
are acutely infected | 2 |
in healthcare workers | 2 |
and n respirators | 2 |
authors consider that | 2 |
uniforms and nonwoven | 2 |
read with interest | 2 |
of systemic treatments | 2 |
have also collaborated | 2 |
not limited to | 2 |
an increased risk | 2 |
y productos sanitarios | 2 |
is preferred to | 2 |
the phase iii | 2 |
in biobadaderm as | 2 |
in the design | 2 |
skin care companies | 2 |
phase clinical trial | 2 |
the potential to | 2 |
in all active | 2 |
conflict of interest | 2 |
consensus study in | 2 |
spread of disease | 2 |
org article s | 2 |
chronic mucocutaneous candidiasis | 2 |
following use of | 2 |
is more specific | 2 |
which is because | 2 |
in the glandular | 2 |
like rash is | 2 |
characteristics are detailed | 2 |
masks and n | 2 |
feagan et al | 2 |
no conflict of | 2 |
study include the | 2 |
significantly increased in | 2 |
treatment group and | 2 |
glycols and polyethylene | 2 |
not involved in | 2 |
to outcomes in | 2 |
lower the risk | 2 |
the following companies | 2 |
for hidradenitis suppurativa | 2 |
glandular cells of | 2 |
nor the severity | 2 |
patients when needed | 2 |
how should i | 2 |
could lower the | 2 |
and severe outcomes | 2 |
n facial masks | 2 |
for treatment of | 2 |
of an n | 2 |
patients receiving biologic | 2 |
included in this | 2 |
classification of the | 2 |
problems of other | 2 |
out of current | 2 |
all biobadaderm patient | 2 |
content of the | 2 |
how should applicants | 2 |
outcomes in a | 2 |
of polyoxyethylenic non | 2 |
with biological drugs | 2 |
disease testing was | 2 |
that we analyzed | 2 |
infections and severe | 2 |
with higher percentages | 2 |
antibody could reduce | 2 |
landscape of the | 2 |
likely to be | 2 |
divided rtis into | 2 |
the start of | 2 |
of n facial | 2 |
inflammatory bowel disease | 2 |
that sexual intercourse | 2 |
dermatitis to facial | 2 |
ongoing international registries | 2 |
the severe acute | 2 |
about current comorbidities | 2 |
using prospective studies | 2 |
p monoclonal antibody | 2 |
for autoimmune diseases | 2 |
being treated with | 2 |
cohort of biobadaderm | 2 |
not significantly increased | 2 |
the general population | 2 |
pandemic has been | 2 |
the age and | 2 |
the context of | 2 |
previously described national | 2 |
al feagan et | 2 |
of incidence with | 2 |
in terms of | 2 |
of viral infections | 2 |
needed icu and | 2 |
has the potential | 2 |
and or paid | 2 |
care is preferred | 2 |
of biobadaderm registry | 2 |
strategies to control | 2 |
of respiratory tract | 2 |
case report with | 2 |
there is an | 2 |
after removal of | 2 |
has been shown | 2 |
autoxidation of polyoxyethylenic | 2 |
no more than | 2 |
of moderate to | 2 |
classic systemic or | 2 |
hydroxychloroquine in the | 2 |
we know the | 2 |
review of the | 2 |
ag l xa | 2 |
of the observed | 2 |
comorbidities like hypertension | 2 |
the end of | 2 |
necessary to confirm | 2 |
comorbidities related to | 2 |
treatments in psoriatic | 2 |
risk of urtis | 2 |
of comorbidities like | 2 |
patients who are | 2 |
of the phase | 2 |
lesions in non | 2 |
suggests that psoriatic | 2 |
data updated on | 2 |
number of covid | 2 |
the potential risk | 2 |
data were reassuring | 2 |
by the spanish | 2 |
end of period | 2 |
updated on july | 2 |
but the funnel | 2 |
to meet the | 2 |
important to note | 2 |
spain with cases | 2 |
to the expected | 2 |
are associated with | 2 |
seen in person | 2 |
combined average of | 2 |
analysis examined hospitalization | 2 |
using the il | 2 |
we estimated the | 2 |
active psoriatic arthritis | 2 |
who are acutely | 2 |
in the context | 2 |
during the coronavirus | 2 |
has been the | 2 |
strength of this | 2 |
incidence with adequate | 2 |
resulting in a | 2 |
in a cohort | 2 |
we collected information | 2 |
alopecia present in | 2 |
care during the | 2 |
of very severe | 2 |
courses of the | 2 |
formaldehyde has been | 2 |
duplicates and those | 2 |
the expected number | 2 |
epidemic and patient | 2 |
findings from the | 2 |
records and contacted | 2 |
severity of covid | 2 |
an n respirator | 2 |
the population of | 2 |
meet the dermatologic | 2 |
price et al | 2 |
and interpretation of | 2 |
male pattern baldness | 2 |
allergen in n | 2 |
ci were calculated | 2 |
in one case | 2 |
were not involved | 2 |
this study therefore | 2 |
other jak inhibitors | 2 |
medicamentos y productos | 2 |
compare significance between | 2 |
is not limited | 2 |
infections associated with | 2 |
is necessary to | 2 |
of the american | 2 |
or approval of | 2 |
studies of incidence | 2 |
de medicamentos y | 2 |
for disease control | 2 |
and that we | 2 |
on my application | 2 |
possibly a byproduct | 2 |
to a recommendation | 2 |
registries based on | 2 |
of psoriatic patients | 2 |
conducted during the | 2 |
than years and | 2 |
spanish medicines and | 2 |
polyethylene glycols peroxides | 2 |
y a qyi | 2 |
biobadaderm as compared | 2 |
the biobadaderm project | 2 |
of the vesicles | 2 |
for each sir | 2 |
the spanish figures | 2 |
was not asymmetric | 2 |
preference for cellulitis | 2 |
part of the | 2 |
in the past | 2 |
group compared to | 2 |
on case notifications | 2 |
acted as consultant | 2 |
clinical trials as | 2 |
rcts which permitted | 2 |
include the lack | 2 |
novartis and ucb | 2 |
at our institution | 2 |
hospital universitario dr | 2 |
funnel plot was | 2 |
therefore avoids problems | 2 |
classification and incidence | 2 |
done during the | 2 |
of teledermatology visits | 2 |
this study is | 2 |
the biobadaderm registry | 2 |
could be a | 2 |
of rtis with | 2 |
how should students | 2 |
textile masks autoxidation | 2 |
be part of | 2 |
cases to the | 2 |
teledermatology visits with | 2 |
during the webinar | 2 |
in person were | 2 |
in our main | 2 |
word of caution | 2 |
hydroxychloroquine and azithromycin | 2 |
with novel coronavirus | 2 |
at the front | 2 |
treatment during the | 2 |
prevalence and risk | 2 |
a phase clinical | 2 |
cases published by | 2 |
students without home | 2 |
observed cases to | 2 |
masks autoxidation of | 2 |
of viral urtis | 2 |
a significantly increased | 2 |
a reference center | 2 |
patients with hidradenitis | 2 |
estimated the age | 2 |
calculated for each | 2 |
reporting items for | 2 |
contact dermatitis and | 2 |
patients may be | 2 |
sex standardized incidence | 2 |
risk of infectious | 2 |
the cohort of | 2 |
and neck surgery | 2 |
of cytokines and | 2 |
and healthcare disparities | 2 |
the spanish medicines | 2 |
interpretation of data | 2 |
systemic treatments in | 2 |
mg kg i | 2 |
ministry of health | 2 |
no conflicts of | 2 |
the number of | 2 |
after air exposure | 2 |
preservative and is | 2 |
polypropylene degradation during | 2 |
there is a | 2 |
consider that it | 2 |
acutely infected with | 2 |
immunosuppressants during the | 2 |
calculate the incidences | 2 |
inflammatory cytokines and | 2 |
need to be | 2 |
a retrospective review | 2 |
with systemic therapy | 2 |
systemic or biologic | 2 |
and from pharmaceutical | 2 |
available at key | 2 |
patients infected with | 2 |
of cases according | 2 |
mediated inflammatory diseases | 2 |
ill patients with | 2 |
sandborn et al | 2 |
confirmations for the | 2 |
cohort of psoriatic | 2 |
in teledermatology were | 2 |
marzano and colleagues | 2 |
the observed cases | 2 |
in the production | 2 |
cases according to | 2 |
preferred reporting items | 2 |
manifestations of covid | 2 |
was significantly higher | 2 |
and to compare | 2 |
access to teledermatology | 2 |
to the general | 2 |
not meet inclusion | 2 |
of the registry | 2 |
population of origin | 2 |
a specific study | 2 |
safety results from | 2 |
and safety results | 2 |
use of biologic | 2 |
facial masks allergic | 2 |
permitted to use | 2 |
years and of | 2 |
residency program director | 2 |
rtis into urtis | 2 |
biologic treatments increase | 2 |
was often not | 2 |
masks allergic contact | 2 |
centers for disease | 2 |
psoriatic patients receiving | 2 |
patient characteristics are | 2 |
or molecular confirmations | 2 |
in our opinion | 2 |
evaluation of an | 2 |
a welldefined base | 2 |
an allergen in | 2 |
have a welldefined | 2 |
know the base | 2 |
hydroxychloroquine and other | 2 |
the profile of | 2 |
use of n | 2 |
unequal access to | 2 |
biobadaderm patient records | 2 |
in the literature | 2 |
lower risk of | 2 |
to submit the | 2 |
host response to | 2 |
control and prevention | 2 |
from the apd | 2 |
collaborated in the | 2 |
et al feagan | 2 |
to care for | 2 |
the cutaneous manifestations | 2 |
showed a lower | 2 |
prepare for the | 2 |
companies have also | 2 |
higher percentages of | 2 |
descalzo gallego infections | 2 |
is because in | 2 |
the content of | 2 |
e m services | 2 |
shifting landscape of | 2 |
that is likely | 2 |
of the cutaneous | 2 |
are summarized in | 2 |
glycol derivatives contact | 2 |
acute respiratory disease | 2 |
without home dermatology | 2 |
decision to submit | 2 |
neither the susceptibility | 2 |
included in biobadaderm | 2 |
department of dermatology | 2 |
published by the | 2 |
controlled voyage trial | 2 |
of mild courses | 2 |